Comparative Efficacy of Janus Kinase Inhibitors (JAKis) for Ulcerative Colitis in Japanese Regional Healthcare Facilities: A Real-World Database Study
FIL showed favorable remission rates, especially in Bio/JAKi-naïve patients, and remained effective after prior failures, suggesting broad applicability. UPA and TOF showed similar remission rates in our cohort.
Authors
- Shiko Kuribayashi (ORCID: https://orcid.org/0000-0002-5067-552X)
- Keigo Sato (ORCID: https://orcid.org/0000-0002-5235-1502)
- Shota Tomaru
- Yuko Kimura
- Hiroko Hosaka (ORCID: https://orcid.org/0000-0002-3483-5351)
- Yoji Takeuchi (ORCID: https://orcid.org/0000-0003-3814-298X)
- Masanori Sekiguchi
- Takashige Masuo
- Kazuhiro Takahashi (ORCID: https://orcid.org/0000-0003-1089-0644)
- Yuki Itoi
- Yoko Hachisu
- Kyoko Marubashi
- Atsuo Iwamoto
- Tomoyuki Masuda (ORCID: https://orcid.org/0000-0001-6429-9468)
- Toshio Uraoka (ORCID: https://orcid.org/0000-0001-7392-8342)
- Hirohito Tanaka
- Yu Hashimoto
Institutions
- Gunma University (JP)
- Fujitsu (Japan) (JP)
- Takamatsu Red Cross Hospital (JP)
- Maebashi Red Cross Hospital (JP)
- Hospital General de Tomelloso (ES)
- National Hospital Organization Takasaki Medical Center (JP)
- Gunma Saiseikai Maebashi Hospital (JP)
- National Hospital Organization (JP)
- Isesaki Fukushima Hospital (JP)
Publication Details
- Journal
- Cureus
- Published
- 2025-11-22
- DOI
- https://doi.org/10.7759/cureus.97500
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00